HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms
The lipoprotein HDL has two important roles: first, it promotes reverse cholesterol transport,
and second, it modulates inflammation. Epidemiological studies show that HDL-cholesterol …
and second, it modulates inflammation. Epidemiological studies show that HDL-cholesterol …
[HTML][HTML] The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review
SR Schoenfeld, S Kasturi, KH Costenbader - Seminars in arthritis and …, 2013 - Elsevier
Objective To perform a systematic review of the literature regarding the epidemiology of the
association between systemic lupus erythematosus (SLE) and atherosclerotic …
association between systemic lupus erythematosus (SLE) and atherosclerotic …
Atualização da diretriz brasileira de dislipidemias e prevenção da aterosclerose–2017
AA Faludi, MCO Izar, JFK Saraiva… - Arquivos brasileiros de …, 2017 - SciELO Brasil
Material de distribuição exclusiva à classe médica. Os Arquivos Brasileiros de Cardiologia
não se responsabilizam pelo acesso indevido a seu conteúdo e que contrarie a …
não se responsabilizam pelo acesso indevido a seu conteúdo e que contrarie a …
Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus
Increased risk of premature cardiovascular disease (CVD) is well recognized in systemic
lupus erythematosus (SLE). Aberrant type I-Interferon (IFN)-neutrophil interactions contribute …
lupus erythematosus (SLE). Aberrant type I-Interferon (IFN)-neutrophil interactions contribute …
Taming lupus—a new understanding of pathogenesis is leading to clinical advances
Z Liu, A Davidson - Nature medicine, 2012 - nature.com
Systemic lupus erythematosus (SLE) is an autoimmune disease that is characterized by the
loss of tolerance to nuclear self antigens, the production of pathogenic autoantibodies and …
loss of tolerance to nuclear self antigens, the production of pathogenic autoantibodies and …
Glucagonlike peptide 1–based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study
Importance Acute pancreatitis has significant morbidity and mortality. Previous studies have
raised the possibility that glucagonlike peptide 1 (GLP-1)–based therapies, including a GLP …
raised the possibility that glucagonlike peptide 1 (GLP-1)–based therapies, including a GLP …
Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies
Suppressing inflammation has been the primary focus of therapies in autoimmune rheumatic
diseases (AIRDs), including rheumatoid arthritis and systemic lupus erythematosus …
diseases (AIRDs), including rheumatoid arthritis and systemic lupus erythematosus …
Cardiovascular disease in systemic lupus erythematosus: a comprehensive update
M Giannelou, CP Mavragani - Journal of autoimmunity, 2017 - Elsevier
Heightened rates of both cardiovascular (CV) events and subclinical atherosclerosis,
documented by imaging and vascular function techniques are well established in systemic …
documented by imaging and vascular function techniques are well established in systemic …
Neutrophil extracellular trap–derived enzymes oxidize high‐density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus
CK Smith, A Vivekanandan‐Giri, C Tang… - Arthritis & …, 2014 - Wiley Online Library
Objective Oxidative stress and oxidized high‐density lipoprotein (HDL) are implicated as risk
factors for cardiovascular disease (CVD) in systemic lupus erythematosus (SLE). Yet, how …
factors for cardiovascular disease (CVD) in systemic lupus erythematosus (SLE). Yet, how …
Accelerated atherosclerosis in patients with SLE—mechanisms and management
Rapid-onset cardiovascular disease (CVD) is a major concern for many patients with
systemic lupus erythematosus (SLE). Cardiovascular events occur more frequently and with …
systemic lupus erythematosus (SLE). Cardiovascular events occur more frequently and with …